Blog

Steve Southwick joins us with over 15 years of experience leading transformative initiatives at the intersection of healthcare and technology. His career has been defined by a passion for solving complex challenges in the life sciences through ...

Join us in welcoming Craig L. Tendler, M.D. to Trial Library as an advisor. Dr. Tendler brings over 30 years of pharmaceutical development expertise, with a distinguished career most recently as Vice President of Oncology Clinical Development and ...

We're thrilled to welcome Emily Wu to our team as our Clinical Data Coordinator. With a Master's in Public Health from UC Davis and previous experience as a Clinical Research Coordinator at UCSF's Genitourinary Oncology department, Emily brings a ...

At Trial Library, we collaborate with leading oncology experts to ensure our Trial Search Platform is transforming clinical trial access for providers and their patients. As part of our SME Spotlight Series, we’re excited to feature ...

We’re excited to welcome Andrea Molyneux to the Trial Library team as our new AI/ML Engineer! With over a decade of experience in machine learning, Andrea brings a deep passion for mission-driven technology and a track record of building AI ...

At Trial Library, we are committed to advancing inclusive, ethical, and patient-centered clinical research—values that resonate deeply with our newest team member, Dr. Eve Pennie.

Danny Cadet is a visionary in clinical trials, blending scientific expertise with a deep commitment to patient-centered research. A Northeastern University graduate, his passion for advancing healthcare took root at Brigham and Women’s Hospital, ...

In the rapidly evolving field of oncology, matching patients to the right clinical trials can be the key to unlocking new treatments and improving outcomes. Dr. Meera Ragavan, our subject matter expert in lung cancer, plays a critical role in ...

Dr. Charles Ryan, a medical oncologist with over 25 years of experience, has devoted much of his career to clinical research in prostate cancer, playing a crucial role in designing and conducting studies ranging from early-phase trials to ...

In this informative conversation, Dr. Hala Borno, CEO and Founder of Trial Library, sits down with Dr. Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, to discuss the vital role of clinical trials in ...

Healthcare Providers are the gatekeepers to patient access for cancer trials. Eight of ten patients who enroll in a cancer trial, do so because of a Healthcare Provider recommendation. However, as a healthcare provider, my experience today ...

Amanda is a dedicated Ally Navigator at Trial Library. She joined Trial Library with extensive patient care experience as a Registered Nurse. Amanda has dedicated her career to serving vulnerable populations through community organizing and ...

As a health technology company, Trial Library has prioritized the security of our platform and data from the very beginning. We are thrilled to announce that Trial Library has officially achieved SOC 2 Type 2 and HIPAA compliance certifications!

We are privileged to include Dr. Kashyap Patel as a Clinical and Scientific Advisor to Trial Library. Dr. Patel is a key opinion leader with extensive leadership experience in oncology. He is the current Chief Executive Officer of Carolina Blood ...

Dr. Josephson is a practicing Urologic Oncologist and partner at Tower Urology, a Los Angeles-based private practice of 10 physicians treating patients across Southern California. Dr. Josephson is one of the leading experts in robotic surgery, ...

The estimated rates of cancer clinical trial participation among eligible patients remain between 5-7% with limited progress over the past two decades (source). Only 1 in 10 Americans reported ever being invited to participate in a clinical trial ...

I see offering clinical trials as an integral part of the delivery of cancer care. For my patients, clinical trials are an opportunity to access therapies and diagnostics that may improve quality and potentially duration of life. Clinical trials ...